Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$1.3 - $2.15 $2,766 - $4,575
2,128 Added 29.66%
9,302 $16,000
Q4 2023

Feb 09, 2024

BUY
$1.4 - $2.46 $2,245 - $3,945
1,604 Added 28.8%
7,174 $14,000
Q3 2023

Nov 13, 2023

SELL
$2.31 - $4.18 $11,563 - $20,925
-5,006 Reduced 47.33%
5,570 $12,000
Q2 2023

Aug 15, 2023

BUY
$4.26 - $6.92 $44,308 - $71,974
10,401 Added 5943.43%
10,576 $45,000
Q1 2023

May 12, 2023

BUY
$5.65 - $7.56 $22 - $30
4 Added 2.34%
175 $1,000
Q4 2022

Feb 13, 2023

BUY
$5.47 - $7.9 $21 - $31
4 Added 2.4%
171 $1,000
Q3 2022

Nov 14, 2022

SELL
$7.42 - $11.39 $7 - $11
-1 Reduced 0.6%
167 $1,000
Q2 2022

Aug 12, 2022

BUY
$4.96 - $7.83 $69 - $109
14 Added 9.09%
168 $1,000
Q1 2022

May 16, 2022

BUY
$6.33 - $9.53 $196 - $295
31 Added 25.2%
154 $1,000
Q4 2021

Feb 14, 2022

SELL
$8.44 - $15.61 $16,880 - $31,220
-2,000 Reduced 94.21%
123 $1,000
Q3 2021

Nov 15, 2021

BUY
$5.9 - $12.54 $118 - $250
20 Added 0.95%
2,123 $23,000
Q2 2021

Aug 16, 2021

SELL
$4.72 - $7.15 $23,250 - $35,220
-4,926 Reduced 70.08%
2,103 $14,000
Q1 2021

May 13, 2021

SELL
$5.13 - $7.24 $471 - $666
-92 Reduced 1.29%
7,029 $39,000
Q4 2020

Feb 09, 2021

BUY
$5.18 - $6.03 $18,606 - $21,659
3,592 Added 101.79%
7,121 $38,000
Q3 2020

Nov 05, 2020

SELL
$4.86 - $7.07 $15,420 - $22,433
-3,173 Reduced 47.34%
3,529 $18,000
Q2 2020

Aug 13, 2020

BUY
$6.44 - $9.45 $42,697 - $62,653
6,630 Added 9208.33%
6,702 $49,000
Q1 2020

May 14, 2020

BUY
$3.94 - $10.93 $283 - $786
72 New
72 $1,000

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $8.97M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.